| Jessica Davis, | |
|
315 S High Street, Pratt, KS 67124-8754 | |
| (620) 388-1356 | |
| Not Available |
| Full Name | Jessica Davis |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 315 S High Street, Pratt, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750766374 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | 2740 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Davis, Po Box 8754, Pratt, KS 67124-8754 Ph: (620) 388-1356 | Jessica Davis, 315 S High Street, Pratt, KS 67124-8754 Ph: (620) 388-1356 |
News Archive
When a patient arrives at a doctor's office with a persistent cough and the sensation of gunk building up in the lungs, the doctor's thought process is essentially the same as it would have been decades ago. There has been no understanding of the affected biological pathways causing the gunk buildup in the lung, nor has there been a diagnostic test for chronic bronchitis.
A pair of proteins may help explain why people with surgically removed colorectal cancer and who are overweight, physically inactive, and follow a Western-pattern diet may have an increased risk of dying of the disease or other causes, Dana-Farber Cancer Institute scientists report in a new study.
Normal brain development requires a precise interplay between neuronal and non-neuronal (also called glial) cells.
Amedisys, Inc., one of America's leading home health nursing companies, today reported its financial results for the three and nine-month periods ended September 30, 2009. We posted record financial performance with net service revenue and net income attributable to Amedisys, Inc., increasing 20.7% and 53.0%, respectively, over the three-month period ended September 30, 2008.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today announced that the U.S. Food and Drug Administration (FDA) has approved TIVORBEX™ (indomethacin) capsules, a nonsteroidal anti-inflammatory drug (NSAID), at 20 mg and 40 mg doses for the treatment of mild to moderate acute pain in adults.
› Verified 9 days ago
Beth Barnard, LMAC, LPC-T Counselor Medicare: Not Enrolled in Medicare Practice Location: 105 W 4th St, Pratt, KS 67124 Phone: 620-672-7546 Fax: 580-824-0676 | |
Amanda Wade, LPC Counselor Medicare: Medicare Enrolled Practice Location: 200 Commodore St, Pratt, KS 67124 Phone: 620-450-1163 | |
Samantha Bauer, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 105 W 4th St, Pratt, KS 67124 Phone: 620-231-5310 | |
Miss Tamara Leaann Johnston, LMSW, LMAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 501 S Ninnescah St, Pratt, KS 67124 Phone: 620-672-7546 Fax: 620-672-7148 |